Dr Reddy's Laboratories Ltd (NYSE:RDY)
$ 15.59 -0.08 (-0.51%) Market Cap: 13.05 Bil Enterprise Value: 12.93 Bil PE Ratio: 25.11 PB Ratio: 3.70 GF Score: 91/100

Dr Reddy's Laboratories Ltd Investor Day Transcript

Jun 21, 2022 / 11:30AM GMT
Release Date Price: $11.02 (+3.55%)
Amit Agarwal;s Laboratories Limited;Head of IR and Director of Finance
Dr. Reddy;FP&A & IR

'- -

So greetings to all of you. And thank you for being here with us today for the Dr. Reddy's Investor Day 2022. I hope all the participants who have joined us are able to -- can view and hear us.

Today, first, the senior leadership team of Dr. Reddy's, Mr. G.V. Prasad, Co-Chairman and Managing Director; Erez Israeli, CEO; Parag Agarwal, CFO; M.V. Ramana, CEO of Branded Markets; Sanjay Sharma, Global Head of Manufacturing; Archana Bhaskar, CHRO; and Jayanth Sridhar, Global Head of Biologics. The management team would take you through the growth levers of our business and our sustainability goals. There will be a Q&A session after the presentation and request the participants to ask their questions during that time. We have also arranged for dinner for in-person participants.

Please note that any reference made on the future outlook should not be construed as a guidance made by the company. These forward-looking statements must be read in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot